Cargando…
Pharmaceutical policies in European countries in response to the global financial crisis
Objective: The objective of this paper is to analyze which pharmaceutical policies European countries applied during the global financial crisis. Methods: We undertook a survey with officials from public authorities for pharmaceutical pricing and reimbursement of 33 European countries represented in...
Autores principales: | Vogler, Sabine, Zimmermann, Nina, Leopold, Christine, de Joncheere, Kees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dr. Zaheer-Ud-Din Babar
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471176/ https://www.ncbi.nlm.nih.gov/pubmed/23093885 http://dx.doi.org/10.5655/smr.v4i2.1004 |
Ejemplares similares
-
The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
por: Vogler, Sabine, et al.
Publicado: (2015) -
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries
por: Leopold, Christine, et al.
Publicado: (2014) -
Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2016) -
Impact of External Price Referencing on Medicine Prices – A Price Comparison Among 14 European Countries
por: Leopold, Christine, et al.
Publicado: (2012) -
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
por: Vogler, Sabine, et al.
Publicado: (2021)